[ad_1]
The head of Eli Lilly’s burgeoning diabetes and obesity franchise is retiring at the end of the year. Mike Mason is leaving after 34 years with the company.
[ad_2]
Source link
[ad_1]
The head of Eli Lilly’s burgeoning diabetes and obesity franchise is retiring at the end of the year. Mike Mason is leaving after 34 years with the company.
[ad_2]
Source link